Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.03 USD
Change Today 0.00 / 0.00%
Volume 0.0
GSAC On Other Exchanges
As of 8:10 PM 03/26/15 All times are local (Market data is delayed by at least 15 minutes).

gelstat corp (GSAC) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/30/14 - $0.08
52 Week Low
12/11/14 - $0.02
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GELSTAT CORP (GSAC)

Related News

No related news articles were found.

gelstat corp (GSAC) Related Businessweek News

No Related Businessweek News Found

gelstat corp (GSAC) Details

GelStat Corporation operates as a consumer healthcare company. The company engages in the development and marketing of over-the-counter and other non-prescription consumer health care products. It offers Gelstat Migraine, a patented homeopathic drug designed to provide acute relief from migraine and migraine-like headaches; and Gelstat Sleep, a sleep aid product. It is also developing various healthcare products that address consumer markets. The company provides its products directly, as well as through independent retailers and pharmacies. GelStat Corporation also sells its products through its Website The company is based in Palm City, the United States.

gelstat corp (GSAC) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

gelstat corp (GSAC) Key Developments

GelStat Corp. Announces Consolidated Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Revenue Guidance for 2015

GelStat Corp. announced consolidated revenue results for the fourth quarter and full year ended December 31, 2014. The company generated consolidated revenue in excess of $750,000 for the fourth quarter. The company generated consolidated revenue in excess of $1.3 million for the full year ended December 31, 2014 led by its wholly owned subsidiary Mastix Medica. For 2015, the company expects growth to continue and revenues to be in the $4.5 to $5.5 million range.

GelStat Corporation Reports Consolidated Earnings Results for the Third Quarter Ended September 30, 2014; Provides Revenue Guidance for the Fourth Quarter Ending December 31, 2014

GelStat Corporation reported consolidated earnings results for the third quarter ended September 30, 2014. For the quarter, the company reported consolidated revenue of $542,477, up 8,800% from $6,157 for the third quarter ended September 30, 2013. Net loss was $457,935 compared to a loss of $28,115 for the third quarter ended September 30, 2013. Net losses for the period ended September 30, 2014 included over $400,000 in non-cash charges. The company increased revenue forecast to over $750,000 for the fourth quarter ending December 31, 2014. The increased revenue expectations are driven by continued strength in operations from recently acquired wholly owned subsidiary Mastix Medica and increasing sales of proprietary healthcare products.

GelStat Corp. to Report Q3, 2014 Results on Nov 15, 2014

GelStat Corp. announced that they will report Q3, 2014 results on Nov 15, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSAC:US $0.03 USD 0.00

GSAC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bristol-Myers Squibb Co $65.26 USD +0.26
View Industry Companies

Industry Analysis


Industry Average

Valuation GSAC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GELSTAT CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at